Navigation Links
Avanir Pharmaceuticals Announces Publication of AVP-825 Pharmacokinetic Data in Journal "Headache"
Date:9/20/2013

ALISO VIEJO, Calif., Sept. 20, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced the publication of a pharmacokinetic (PK) study of AVP-825, a novel Breath Powered device used to deliver sumatriptan powder intranasally for the treatment of acute migraine. This randomized study characterized the PK profile of 22 mg sumatriptan delivered through AVP-825 compared with the PK profiles of three sumatriptan products: 20 mg liquid nasal spray, 100 mg oral tablet and 6 mg subcutaneous injection.

(Logo: http://photos.prnewswire.com/prnh/20130207/LA55901LOGO)

The study, conducted in 20 healthy subjects, found that AVP-825 was a highly efficient means of sumatriptan delivery, producing a faster rise in sumatriptan plasma concentration, a higher peak exposure, and greater early exposure in the crucial first minutes after treatment than liquid nasal spray, despite delivering a lower dose.  Specifically, AVP-825 (16 mg delivered dose) produced 27% higher peak exposure (Cmax 20.8 ng/mL vs. 16.4 ng/mL), and 75% more systemic exposure (AUC0-15 2.1 ng*hr/mL vs. 1.2 ng*hr/mL) during the critical first 15 minutes post dose than liquid nasal spray (20 mg delivered dose). On a dose-adjusted basis, this represents over 50% higher peak exposure and doubling of early exposure. AVP-825 delivery was also associated with three times as much drug into the plasma in the first 15 minutes post dose (AUC0-15  2.1 ng*hr/mL vs. 0.7 ng*hr/mL) than obtained with 100 mg oral tablet.

In addition to fast delivery, important for providing fast migraine relief, the study demonstrated that AVP-825 is associated with greater overall intranasal delivery efficiency, with the average total drug exposure per milligram one third higher than th
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Wockhardt
2. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Actavis
3. Avanir Pharmaceuticals Announces Publication of PRISM Pseudobulbar Affect Registry Findings
4. Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Sandoz
5. Avanir Pharmaceuticals Announces Diabetes Co-Promotion Agreement with Merck
6. Avanir Pharmaceuticals Reports Fiscal 2013 Third Quarter Financial and Business Results
7. Avanir Pharmaceuticals to Participate in Two Conferences in August
8. Avanir Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
9. Avanir Pharmaceuticals Announces Accelerated Development Path for AVP-786 Following Successful Pre-IND Meeting with FDA
10. Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences
11. Avanir Pharmaceuticals Reports Fiscal 2013 Second Quarter Financial and Business Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 19, 2014  Newport Corporation (NASDAQ: ... has joined the company,s Board of Directors.  Dr. ... a director of Evans Analytical Group, a leading ... analytical services to companies in a wide range ... Evans Analytical Group, Dr. Kadia spent nine years ...
(Date:12/19/2014)... Breckenridge Pharmaceutical, Inc. announced today that it ... Pvt. Ltd. ( Hyderabad, India ) under ... ANDAs.  Under the terms of the agreement, MSN will ... for the U.S. market, and Breckenridge will market and ... have agreed to develop an oral antibiotic with current ...
(Date:12/19/2014)... CHAPEL HILL, N.C. , Dec. 19, 2014 ... marketplace, innovative consumer research and marketing communication tools ... rich and globally competitive – consequently consumers, desires, ... In this environment, market research groups across ... research and marketing communication tools. However, the adoption ...
Breaking Medicine Technology:Siddhartha Kadia, Ph.D. Joins Board of Directors of Newport Corporation 2Breckenridge Pharmaceutical signs Multi-Product Generic Agreement with MSN Laboratories Pvt. Ltd. 2Study Uncovers New Tools and Techniques for Understanding Consumer Decision Making 2
... Bionovo, Inc. (NASDAQ: BNVI ), a pharmaceutical company ... treatments for women,s health and cancer, today announced it will ... their lead drug candidate for postmenopausal symptoms, Menerba ™ ... 13th Annual World Congress on Menopause in Rome, Italy on ...
... Inc. (Nasdaq: ISIS ), the leader in antisense ... at Jefferies, 2011 Global Healthcare Conference on Thursday, June 09, ... York. A live audio webcast of the presentation ... the Company,s Web site, www.isispharm.com .  A replay of ...
Cached Medicine Technology:Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause 2Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause 3Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause 4
(Date:12/19/2014)... 19, 2014 Energy Textiles is ... now available. Celliant, the world’s leading responsive textile, ... pillowcases. , There are a number of benefits ... increased oxygenation and balanced body temperature; which can ... pain relief; enhanced athletic performance; and overall wellness. ...
(Date:12/19/2014)... December 19, 2014 SuperCloset raises the ... Rooms. SuperCloset continues to offer indoor growers the most ... of the new SuperClone Rooms with the award winning ... turnkey indoor hydroponic grow room setup. , The SuperClone ... SuperCloset’s SuperPonic SuperCloner 50 . The ...
(Date:12/19/2014)... An evening dress is perfect for any occasion and ... distinguished dresses retailer, has unveiled its new selection of evening ... great shopping platform. Customers can view more at ... has been accepted and praised by customers for many years. ... for clients. In order to expand its market share, the ...
(Date:12/19/2014)... Dec. 19, 2014 (HealthDay News) -- New research warns parents that ... lives at risk. Nearly half of teen drivers killed in ... were at least 11 years old and often lacked important safety ... Eighty-two percent of teen drivers killed in crashes were in cars ... to 10 years old, 31 percent were in cars 11 to ...
(Date:12/19/2014)... Potentially illness-causing E. coli bacteria were found on nearly ... a new study. Researchers checked cilantro, basil and ... in Los Angeles and Orange counties in California, and ... tested, 24 percent were positive for E. coli. One ... Both types of bacteria can cause sometimes serious ...
Breaking Medicine News(10 mins):Health News:Energy Textiles Launches Celliant Revitalizing Bedsheets 2Health News:SuperCloset Continues to Innovate with New Complete Indoor Grow Room Packages, The SuperClone Rooms are the Newest Addition to the Award Winning SuperRoom Lineup 2Health News:Attractive Evening Dresses Announced by Discount-Dress.com 2Health News:Older Cars a Bad Choice for Younger Drivers 2Health News:E. Coli Germs Found on Farmers Market Herbs 2
... In an effort to extend the length of a ... Baptist Medical Center are partnering with colleagues from across the ... by the US National Institute on Aging (NIA). ... aims to assess whether aspirin can not only prolong life, ...
... HealthDay Reporter , WEDNESDAY, July 7 (HealthDay News) ... cancer is less accurate when done in the summer than ... Although the particular brand of test used in the ... the United States, the findings are of interest to U.S. ...
... ... FDA reports of the shocking conditions in manufacturing plants have pediatricians and parents concerned ... ... the year there have been numerous recalls of infants’ and children’s over-the-counter (OTC) pharmaceutical ...
... detection today is X-ray mammography, which takes images of ... are several disadvantages to using X-rays for breast cancer ... and the high costs, which limit their wide use ... depending on the age of the patient and tissue ...
... D.C. (July 1, 2010) -- Thousands of scientists and ... meet at the 52nd meeting of the American Association ... 22, 2010 in Philadelphia, Pennsylvania. They will present the ... and discuss the safety and regulatory issues facing the ...
... , WEDNESDAY, July 7 (HealthDay News) -- ... chronic low back pain influence how they manage their ... ability to find, understand and use health information. Low ... in many chronic conditions, but this relationship has not ...
Cached Medicine News:Health News:Can aspirin prolong a healthy life? 2Health News:Could Hot Weather Affect Results of a Colorectal Cancer Test? 2Health News:Could Hot Weather Affect Results of a Colorectal Cancer Test? 3Health News:Could Hot Weather Affect Results of a Colorectal Cancer Test? 4Health News:Safety in Children's Pain Relief Products a Primary Concern 2Health News:Safety in Children's Pain Relief Products a Primary Concern 3Health News:Mathematical models for breast cancer detection with microwave tomography are cheaper and less risky 2Health News:Understanding Back Pain May Improve Management, Study Suggests 2
The Fluoroskan Ascent, a dedicated microplate fluorometer, offers high sensitivity for a wide variety of fluorometric applications....
The VersaFluor cuvette fluorometer is a fast and simple way to quantitate DNA, RNA, and proteins, to detect apoptosis, and to perform reporter enzyme assays with the high level of sensitivity and sel...
... unique microprocessor-controlled filter wheels for wavelength selection ... filter wheels can be programmed for excitation ... With this fluorometer, you do not have ... wavelengths. The C&L Dye Fluorometer can measure ...
The TBS-380 Fluorometer is an economical, sensitive fluorometer designed for quick, easy, and accurate fluorescent measurements....
Medicine Products: